Cargando…

Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness

Neuropeptides are auxiliary messenger molecules that always co-exist in nerve cells with one or more small molecule (classic) neurotransmitters. Neuropeptides act both as transmitters and trophic factors, and play a role particularly when the nervous system is challenged, as by injury, pain or stres...

Descripción completa

Detalles Bibliográficos
Autores principales: Hökfelt, Tomas, Barde, Swapnali, Xu, Zhi-Qing David, Kuteeva, Eugenia, Rüegg, Joelle, Le Maitre, Erwan, Risling, Mårten, Kehr, Jan, Ihnatko, Robert, Theodorsson, Elvar, Palkovits, Miklos, Deakin, William, Bagdy, Gyorgy, Juhasz, Gabriella, Prud’homme, H. Josée, Mechawar, Naguib, Diaz-Heijtz, Rochellys, Ögren, Sven Ove
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309708/
https://www.ncbi.nlm.nih.gov/pubmed/30627087
http://dx.doi.org/10.3389/fncir.2018.00106
_version_ 1783383379238977536
author Hökfelt, Tomas
Barde, Swapnali
Xu, Zhi-Qing David
Kuteeva, Eugenia
Rüegg, Joelle
Le Maitre, Erwan
Risling, Mårten
Kehr, Jan
Ihnatko, Robert
Theodorsson, Elvar
Palkovits, Miklos
Deakin, William
Bagdy, Gyorgy
Juhasz, Gabriella
Prud’homme, H. Josée
Mechawar, Naguib
Diaz-Heijtz, Rochellys
Ögren, Sven Ove
author_facet Hökfelt, Tomas
Barde, Swapnali
Xu, Zhi-Qing David
Kuteeva, Eugenia
Rüegg, Joelle
Le Maitre, Erwan
Risling, Mårten
Kehr, Jan
Ihnatko, Robert
Theodorsson, Elvar
Palkovits, Miklos
Deakin, William
Bagdy, Gyorgy
Juhasz, Gabriella
Prud’homme, H. Josée
Mechawar, Naguib
Diaz-Heijtz, Rochellys
Ögren, Sven Ove
author_sort Hökfelt, Tomas
collection PubMed
description Neuropeptides are auxiliary messenger molecules that always co-exist in nerve cells with one or more small molecule (classic) neurotransmitters. Neuropeptides act both as transmitters and trophic factors, and play a role particularly when the nervous system is challenged, as by injury, pain or stress. Here neuropeptides and coexistence in mammals are reviewed, but with special focus on the 29/30 amino acid galanin and its three receptors GalR1, -R2 and -R3. In particular, galanin’s role as a co-transmitter in both rodent and human noradrenergic locus coeruleus (LC) neurons is addressed. Extensive experimental animal data strongly suggest a role for the galanin system in depression–like behavior. The translational potential of these results was tested by studying the galanin system in postmortem human brains, first in normal brains, and then in a comparison of five regions of brains obtained from depressed people who committed suicide, and from matched controls. The distribution of galanin and the four galanin system transcripts in the normal human brain was determined, and selective and parallel changes in levels of transcripts and DNA methylation for galanin and its three receptors were assessed in depressed patients who committed suicide: upregulation of transcripts, e.g., for galanin and GalR3 in LC, paralleled by a decrease in DNA methylation, suggesting involvement of epigenetic mechanisms. It is hypothesized that, when exposed to severe stress, the noradrenergic LC neurons fire in bursts and release galanin from their soma/dendrites. Galanin then acts on somato-dendritic, inhibitory galanin autoreceptors, opening potassium channels and inhibiting firing. The purpose of these autoreceptors is to act as a ‘brake’ to prevent overexcitation, a brake that is also part of resilience to stress that protects against depression. Depression then arises when the inhibition is too strong and long lasting – a maladaption, allostatic load, leading to depletion of NA levels in the forebrain. It is suggested that disinhibition by a galanin antagonist may have antidepressant activity by restoring forebrain NA levels. A role of galanin in depression is also supported by a recent candidate gene study, showing that variants in genes for galanin and its three receptors confer increased risk of depression and anxiety in people who experienced childhood adversity or recent negative life events. In summary, galanin, a neuropeptide coexisting in LC neurons, may participate in the mechanism underlying resilience against a serious and common disorder, MDD. Existing and further results may lead to an increased understanding of how this illness develops, which in turn could provide a basis for its treatment.
format Online
Article
Text
id pubmed-6309708
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63097082019-01-09 Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness Hökfelt, Tomas Barde, Swapnali Xu, Zhi-Qing David Kuteeva, Eugenia Rüegg, Joelle Le Maitre, Erwan Risling, Mårten Kehr, Jan Ihnatko, Robert Theodorsson, Elvar Palkovits, Miklos Deakin, William Bagdy, Gyorgy Juhasz, Gabriella Prud’homme, H. Josée Mechawar, Naguib Diaz-Heijtz, Rochellys Ögren, Sven Ove Front Neural Circuits Neuroscience Neuropeptides are auxiliary messenger molecules that always co-exist in nerve cells with one or more small molecule (classic) neurotransmitters. Neuropeptides act both as transmitters and trophic factors, and play a role particularly when the nervous system is challenged, as by injury, pain or stress. Here neuropeptides and coexistence in mammals are reviewed, but with special focus on the 29/30 amino acid galanin and its three receptors GalR1, -R2 and -R3. In particular, galanin’s role as a co-transmitter in both rodent and human noradrenergic locus coeruleus (LC) neurons is addressed. Extensive experimental animal data strongly suggest a role for the galanin system in depression–like behavior. The translational potential of these results was tested by studying the galanin system in postmortem human brains, first in normal brains, and then in a comparison of five regions of brains obtained from depressed people who committed suicide, and from matched controls. The distribution of galanin and the four galanin system transcripts in the normal human brain was determined, and selective and parallel changes in levels of transcripts and DNA methylation for galanin and its three receptors were assessed in depressed patients who committed suicide: upregulation of transcripts, e.g., for galanin and GalR3 in LC, paralleled by a decrease in DNA methylation, suggesting involvement of epigenetic mechanisms. It is hypothesized that, when exposed to severe stress, the noradrenergic LC neurons fire in bursts and release galanin from their soma/dendrites. Galanin then acts on somato-dendritic, inhibitory galanin autoreceptors, opening potassium channels and inhibiting firing. The purpose of these autoreceptors is to act as a ‘brake’ to prevent overexcitation, a brake that is also part of resilience to stress that protects against depression. Depression then arises when the inhibition is too strong and long lasting – a maladaption, allostatic load, leading to depletion of NA levels in the forebrain. It is suggested that disinhibition by a galanin antagonist may have antidepressant activity by restoring forebrain NA levels. A role of galanin in depression is also supported by a recent candidate gene study, showing that variants in genes for galanin and its three receptors confer increased risk of depression and anxiety in people who experienced childhood adversity or recent negative life events. In summary, galanin, a neuropeptide coexisting in LC neurons, may participate in the mechanism underlying resilience against a serious and common disorder, MDD. Existing and further results may lead to an increased understanding of how this illness develops, which in turn could provide a basis for its treatment. Frontiers Media S.A. 2018-12-21 /pmc/articles/PMC6309708/ /pubmed/30627087 http://dx.doi.org/10.3389/fncir.2018.00106 Text en Copyright © 2018 Hökfelt, Barde, Xu, Kuteeva, Rüegg, Le Maitre, Risling, Kehr, Ihnatko, Theodorsson, Palkovits, Deakin, Bagdy, Juhasz, Prud’homme, Mechawar, Diaz-Heijtz and Ögren. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Hökfelt, Tomas
Barde, Swapnali
Xu, Zhi-Qing David
Kuteeva, Eugenia
Rüegg, Joelle
Le Maitre, Erwan
Risling, Mårten
Kehr, Jan
Ihnatko, Robert
Theodorsson, Elvar
Palkovits, Miklos
Deakin, William
Bagdy, Gyorgy
Juhasz, Gabriella
Prud’homme, H. Josée
Mechawar, Naguib
Diaz-Heijtz, Rochellys
Ögren, Sven Ove
Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness
title Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness
title_full Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness
title_fullStr Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness
title_full_unstemmed Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness
title_short Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness
title_sort neuropeptide and small transmitter coexistence: fundamental studies and relevance to mental illness
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309708/
https://www.ncbi.nlm.nih.gov/pubmed/30627087
http://dx.doi.org/10.3389/fncir.2018.00106
work_keys_str_mv AT hokfelttomas neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness
AT bardeswapnali neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness
AT xuzhiqingdavid neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness
AT kuteevaeugenia neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness
AT rueggjoelle neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness
AT lemaitreerwan neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness
AT rislingmarten neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness
AT kehrjan neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness
AT ihnatkorobert neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness
AT theodorssonelvar neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness
AT palkovitsmiklos neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness
AT deakinwilliam neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness
AT bagdygyorgy neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness
AT juhaszgabriella neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness
AT prudhommehjosee neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness
AT mechawarnaguib neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness
AT diazheijtzrochellys neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness
AT ogrensvenove neuropeptideandsmalltransmittercoexistencefundamentalstudiesandrelevancetomentalillness